Hemlibra “Now Approved and Available” Website for HCPs Jan 24, 2018Jan 21, 2018 Brand: Hemlibra (emicizumab-kxwh), Injection Parent Company: Genentech Drug Type: Boxed Warning Drug Category: Hematology Campaign: now-approved, Now Available Targeting: HCPs Patient Website: https://www.hemlibra.com/ HCP Website: https://www.hemlibra.com/hcp.html Homepage Homepage (Mobile) Mobile Menu Mechanism of Action Dosing Breakthrough Bleeds Financial Assistance